SOPHiA GENETICS S.A. (SOPH) Stock Score, Valuation & Financial Research
SOPHiA GENETICS S.A. is in the Healthcare sector and Medical - Healthcare Information Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 20/100.
Quick answer for SOPH
SOPHiA GENETICS S.A. currently has a Wall Street Score of 20/100. The stored market price is $7.87. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What SOPHiA GENETICS S.A. does
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
SOPH financial snapshot
- Wall Street Score:
- 20/100
- Current price:
- $7.87
- Market capitalization:
- $660.3M
- Revenue:
- $81.2M
- Net income:
- $-80.9M
- Free cash flow:
- $-38.6M
- Cash:
- $65.4M
- Total debt:
- $62.4M
- EPS:
- -1.17
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 16/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $-38.6M, showing cash burn in the current stored period.
- The balance sheet shows $65.4M of cash versus $62.4M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research SOPH
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.